CompletedNot Applicable

Interest of Artificial Intelligence in Cancer Screening Colonoscopy

France194 participantsStarted 2021-10-21

Plain-language summary

Artificial Intelligence (AI) to predict the histology of polyps per colonoscopy, offers a promising solution to reduce variation in colonoscopy performance. This new and innovative non-invasive technology will improve the quality of screening colonoscopies, and reduce the costs of colorectal cancer screening. The aim of the study is to performed a cross-sectional, multi-center study evaluating the diagnostic performance of the CAD EYE automatic characterization system for the histology of colonic polyps in colorectal cancer screening colonoscopy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years of age with indication for colonoscopy as part of a screening colonoscopy, after a positive immunological test, and/or for personal or family history of colon cancer (before 60 years), personal history of colonic adenoma. * Patient with at least one polyp detected, resect and removed during colonoscopy, for histological analysis Exclusion Criteria: * Guardianship or protection, * pregnancy, * not fluent in French or illiterate, * lack of health care

What they're measuring

Estimation of the sensitivity of the automatic characterization system CAD EYE.

Timeframe: Inclusion date (date of the colonoscopy)

Trial details

NCT IDNCT04921488

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-01-25

View on ClinicalTrials.gov More Colonoscopy trials